Epidemiology of nontuberculous mycobacterial lung disease and Tuberculosis, Hawaii, USA

Emerging Infectious Diseases

Volumn 23, Issue 3, 2017, Pages 439-447

  Adjemian, Jennifer ^a,b   Frankland, Timothy B ^c   Daida, Yihe G ^c   Honda, Jennifer R ^d,e   Olivier, Kenneth N ^f   Zelazny, Adrian ^b   Honda, Stacey ^c   Prevots, D Rebecca ^b  

^a U S PUBLIC HEALTH SERVICE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

^f Office of Biostatistics Research National Heart Lung and Blood Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRONCHIECTASIS; COCCIDIOIDOMYCOSIS; COMORBIDITY; CONTROLLED STUDY; ETHNICITY; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; NONHUMAN; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; ADOLESCENT; HAWAII; LUNG DISEASE; MICROBIOLOGY; MIDDLE AGED; TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HAWAII; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; TUBERCULOSIS; YOUNG ADULT;

EID: 85013345413     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2303.161827     Document Type: Article

References (34)

1. Adjemian J, Olivier KN, Seitz A, Holland S, Prevots R. Prevalence of pulmonary nontuberculous mycobacterial infections among U.S. Medicare beneficiaries, 1997–2007. Am J Respir Crit Care Med. 2012;185:881–6. http://dx.doi.org/10.1164/rccm.201111-2016OC.
2. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182:970–6. http://dx.doi.org/10.1164/rccm.201002-0310OC.
3. Thomson RM. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010;16:1576–83. http://dx.doi.org/10.3201/eid1610.091201.
4. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23:553–67. http://dx.doi.org/10.1016/S0272-5231(02)00019-9.
5. Ringshausen FC, Apel RM, Bange FC, de Roux A, Pletz MW, Rademacher J, et al. Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011. BMC Infect Dis. 2013;13:231. http://dx.doi.org/10.1186/1471-2334-13-231.
6. Lee SK, Lee EJ, Kim SK, Chang J, Jeong SH, Kang YA. Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea. Scand J Infect Dis. 2012;44:733–8. http://dx.doi.org/10.3109/00365548.2012.681695.
7. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario,1997–2003. Thorax. 2007;62:661–6. http://dx.doi.org/10.1136/thx.2006.070797.
8. Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998–2010. Emerg Infect Dis. 2013;19:1889–91. http://dx.doi.org/10.3201/eid1911.130737.
9. Brode SK, Daley CL, Marras TK. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. Int J Tuberc Lung Dis. 2014;18:1370–7. http://dx.doi.org/10.5588/ijtld.14.0120.
10. Mirsaeidi M, Machado RF, Garcia JG, Schraufnagel DE. Nontuberculous mycobacterial disease mortality in the United States, 1999–2010: a population-based comparative study. PLoS One. 2014;9:e91879. http://dx.doi.org/10.1371/journal.pone.0091879.
11. Alami NN, Yuen CM, Miramontes R, Pratt R, Price SF, Navin TR. Trends in tuberculosis—United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63:229–33.
12. Scott C, Kirking HL, Jeffries C, Price SF, Pratt R. Tuberculosis trends—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:265–9.
13. Gryn T, Gambino C. The foreign born from Asia: 2011. American Community Survey Briefs. Washington: US Census Bureau; 2012 [cited 2016 Sep 12]. https://www.census.gov/prod/2012pubs/acsbr11-06.pdf.
14. Adjemian J, Olivier K, Seitz A, Holland S, Prevots R. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med. 2012;186: 553–8. https://dx.doi.org/10.1164%2Frccm.201205-0913OC.
15. US Census Bureau. Quick facts, Hawaii. 2010 [cited 2016 Sep 12]]. http://www.census.gov/quickfacts/map/IPE120213/15.
16. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. http://dx.doi.org/10.1164/rccm.200604-571ST.
17. State of Hawaii Department of Health Tuberculosis Control Program. Data and statistics. 2014 [cited 2014 Jul 16]. http://health.hawaii.gov/tb/data-statistics.
18. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182:977– 82. http://dx.doi.org/10.1164/rccm.201003-0503OC.
19. Smith GS, Ghio AJ, Stout JE, Messier KP, Hudgens EE, Murphy MS, et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006–2010. J Infect. 2016;72:678–86. http://dx.doi.org/10.1016/j.jinf.2016.03.008.
20. Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis. 2008;14:390–6. http://dx.doi.org/10.3201/eid1403.061143.
21. Hennessee CT, Seo JS, Alvarez AM, Li QX. Polycyclic aromatic hydrocarbon-degrading species isolated from Hawaiian soils: Mycobacterium crocinum sp. nov., Mycobacterium pallens sp. nov., Mycobacterium rutilum sp. nov., Mycobacterium rufum sp. nov. and Mycobacterium aromaticivorans sp. nov. Int J Syst Evol Microbiol. 2009;59:378–87. http://dx.doi.org/10.1099/ijs.0.65827-0.
22. US Department of Agriculture. Soil survey of the territory of Hawaii: islands of Hawaii, Kauaii, Lanai, Maui, Molokai, and Oahu. Soil Survey Series. 1955;1939:1–64.
23. Kirschner RA Jr, Parker BC, Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis. 1992;145:271–5. http://dx.doi.org/10.1164/ajrccm/145.2_Pt_1.271.
24. Baumgardner DJ. Soil-related bacterial and fungal infections. J Am Board Fam Med. 2012;25:734–44. http://dx.doi.org/10.3122/jabfm.2012.05.110226.
25. Kazda J, Pavlik I, Falkinham JO III. Hruska K. The ecology of mycobacteria: impact on animal’s and human’s health. New York: Springer Science & Business Media; 2010. p. 160–3.
26. Adjemian J, Olivier KN, Prevots DR. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med. 2014;190:581–6. http://dx.doi.org/10.1164/rccm.201405-0884OC.
27. Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36:13–34. http://dx.doi.org/10.1016/j. ccm.2014.10.002.
28. Morimoto K, Iwai K, Uchimura K, Okumura M, Yoshiyama T, Yoshimori K, et al. A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc. 2014;11:1–8. http://dx.doi.org/10.1513/AnnalsATS.201303-067OC.
29. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006;129:341–8. http://dx.doi.org/10.1378/chest.129.2.341.
30. Lai CC, Tan CK, Chou CH, Hsu HL, Liao CH, Huang YT, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis. 2010;16:294–6. http://dx.doi.org/10.3201/eid1602.090675.
31. CDC. Use of race and ethnicity in public health surveillance. Summary of the CDC/ATSDR workshop. Atlanta, Georgia, March 1–2, 1993. MMWR Recomm Rep. 1993;42 (RR-10):1–16.
32. Bloss E, Holtz TH, Jereb J, Redd JT, Podewils LJ, Cheek JE, et al. Tuberculosis in indigenous peoples in the U.S., 2003–2008. Public Health Rep. 2011;126:677–89.
33. Siu AL, Bibbins-Domingo K, Grossman DC, Davidson KW, Epling JW Jr, García FA, et al. Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:1372–7. http://dx.doi.org/10.1001/jama.2016.2638.
34. Herzog TA, Pokhrel P. Ethnic differences in smoking rate, nicotine dependence, and cessation-related variables among adult smokers in Hawaii. J Community Health. 2012;37:1226–33. http://dx.doi.org/10.1007/s10900-012-9558-8.